Related Experiment Video
Updated: Apr 26, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Serotonin syndrome
Stefan Alusik1, Dagmar Kalatova2, Zoltan Paluch2
1Institute for Postgraduate Medical Education, Charles University, Prague, Czech Republic.
Serotonin syndrome, a serious condition, is explored historically and pathologically. This review details its clinical signs, diagnosis, and treatment, focusing on causative drugs and genetic factors.
Area of Science:
- Clinical Pharmacology
- Neuroscience
- Toxicology
Background:
- Serotonin syndrome is a potentially life-threatening condition.
- It arises from excessive serotonergic activity in the central nervous system.
- Understanding its nuances is critical for patient safety.
Purpose of the Study:
- To provide a comprehensive overview of serotonin syndrome.
- To contextualize the condition historically and explore its pathophysiology.
- To detail clinical presentation, diagnosis, and management strategies.
Main Methods:
- Literature review of serotonin syndrome.
- Analysis of historical context and pathophysiology.
- Detailed examination of clinical manifestations, diagnostic criteria, and differential diagnoses.
- Focus on causative agents and relevant genetic polymorphisms.
Main Results:
- Serotonin syndrome presents with a spectrum of symptoms.
- Accurate diagnosis relies on specific clinical criteria and excluding other conditions.
- Management involves drug withdrawal and supportive care, with potential for specific interventions.
Conclusions:
- Serotonin syndrome requires prompt recognition and management.
- Causative drug identification and understanding genetic predispositions are key.
- This review offers a detailed resource for clinicians managing this condition.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Toxidromes: Clinical Features
G-protein Coupled Receptors
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

